文献番号 出願番号 出願日 発明の名称 出願人/権利者
US2023349909 (A1) US202318339853 20230622 IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY UNIV SAITAMA MEDICAL [JP]
JP2023158566 (A) JP20220068481 20220418 METHOD AND SYSTEM FOR MEASURING FLOW VELOCITY AND/OR FLOW RATE OF DISCHARGED URINE UNIV SAITAMA; UNIV SAITAMA MEDICAL
JP2023154950 (A) JP20220064611 20220408 METHOD FOR PREDICTING PROGNOSIS OF ADJUVANT CHEMOTHERAPY FOR CANCER AND REAGENT FOR USE THEREIN UNIV SAITAMA MEDICAL
CN116634923 (A) CN20218086258 20211222 Analysis system, analysis method, data acquisition device for analysis, and program for analysis UNIV SAITAMA MEDICAL
WO2023149558 (A1) WO2023JP03666 20230203 SYSTEM FOR ASSISTING RADIOTHERAPY OF CERVICAL CANCER, METHOD FOR ASSISTING RADIOTHERAPY OF CERVICAL CANCER, AND PROGRAM FOR ASSISTING RADIOTHERAPY OF CERVICAL CANCER UNIV SAITAMA MEDICAL [JP]
KR20230062834 (A) KR20237008651 20210907 BIOMARKER FOR PREDICTING RESPONSE TO CANCER TREATMENT UNIV SAITAMA MEDICAL [JP]
JP2023041409 (A) JP20210148772 20210913 DRIPPING SENSOR AND DRIPPING MONITORING DEVICE UNIV SAITAMA MEDICAL; COSMIC ME CO LTD
JP2023035019 (A) JP20210141591 20210831 ANIMAL MODEL AND PRODUCTION METHOD THEREOF, AND CALCIFICATION AGENT UNIV SAITAMA MEDICAL; UNIV TOHOKU
JP2023034907 (A) JP20210141390 20210831 PHANTOM FOR MRI T1 rho MAPPING AND MANUFACTURING METHOD OF PHANTOM UNIV SAITAMA MEDICAL; UNIV TOYAMA PREFECTURAL
MX2020008582 (A) MX20200008582 20190304 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING HETEROTOPIC OSSIFICATION. UNIV SAITAMA MEDICAL [JP]
JP2022178318 (A) JP20210085044 20210520 BIO-INFORMATION MANAGEMENT SYSTEM, BIO-INFORMATION MANAGEMENT METHOD, AND BIO-INFORMATION MANAGEMENT PROGRAM UNIV SAITAMA MEDICAL; TS PRODUCTS CO LTD
JP2022174704 (A) JP20210120160 20210721 PATIENT POSITIONING SUPPORT SYSTEM. PATIENT POSITIONING SUPPORT METHOD, PATIENT POSITIONING SUPPORT PROGRAM, INTERFERENCE DETERMINATION SUPPORT SYSTEM, RADIOTHERAPY PLANNING SUPPORT SYSTEM, AND RADIOTHERAPY SKILL TRAINING SYSTEM UNIV SAITAMA MEDICAL
WO2022185742 (A1) WO2022JP01353 20220117 PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME UNIV SAITAMA MEDICAL [JP]
US2022267453 (A1) US202017629715 20200722 ANTIBODY RECOGNIZING EXTRACELLULAR REGION OF ALK2/ACVR1 UNIV SAITAMA MEDICAL [JP]; DAIICHI SANKYO CO LTD [JP]
US2022270245 (A1) US202017629570 20200722 ESTIMATOR LEARNING DEVICE, ESTIMATOR LEARNING METHOD, AND ESTIMATOR LEARNING PROGRAM UNIV SAITAMA MEDICAL [JP]; UNIV KYUSHU NAT UNIV CORP [JP]
JP2022117411 (A) JP20210162653 20211001 RODENT HAVING RODENT-MUTANT ALK2 GENE UNIV SAITAMA MEDICAL
WO2022168971 (A1) WO2022JP04638 20220207 METHOD FOR CONTROLLING IMPLANTATION RATE IN MAMMAL, AGENT FOR INCREASING IMPLANTATION RATE IN MAMMAL, AND MEDICINE UNIV SAITAMA MEDICAL [JP]
US2022223239 (A1) US202017609865 20200507 DETERMINATION DEVICE, DETERMINATION METHOD, AND DETERMINATION PROGRAM UNIV SAITAMA MEDICAL [JP]
EP4260873 (A1) EP20210906560 20211213 COMBINATION DRUG FOR TREATING KIDNEY CANCER AND THERAPEUTIC EFFECT ENHANCER FOR TYROSINE KINASE INHIBITOR UNIV SAITAMA MEDICAL [JP]
WO2022080327 (A1) WO2021JP37615 20211011 ESTIMATOR LEARNING DEVICE, ESTIMATOR LEARNING METHOD, AND ESTIMATOR LEARNING PROGRAM UNIV SAITAMA MEDICAL [JP]
JP2022055095 (A) JP20200162474 20200928 STENT AND STENT DELIVERY SYSTEM UMIDAS INC; UNIV SAITAMA MEDICAL
US2022107324 (A1) US202017432744 20200219 PERIPHERAL BLOOD BIOMARKER FOR EVALUATING ANTI-TUMOR IMMUNE EFFECT OF RADIATION THERAPY UNIV SAITAMA MEDICAL [JP]
US2022096552 (A1) US202017432819 20200219 METHOD AND COMPOSITION FOR PREDICTING LONG-TERM SURVIVAL IN CANCER IMMUNOTHERAPY UNIV SAITAMA MEDICAL [JP]
WO2022050230 (A1) WO2021JP31777 20210830 COMPOSITION INHIBITING ACTIVATION OF ADENOSINE RECEPTOR UNIV SAITAMA MEDICAL [JP]
US2022073988 (A1) US201917299141 20191205 METHOD FOR PREDICTING EFFICACY OF RHEUMATOID ARTHRITIS THERAPEUTIC AGENT AND BIOMARKER USED THEREIN DNA CHIP RESEARCH INC [JP]; UNIV KEIO [JP]; UNIV SAITAMA MEDICAL [JP]
WO2022044788 (A1) WO2021JP29473 20210810 DOUBLE-STRANDED NUCLEIC ACID MOLECULE, DNA, VECTOR, FEMALE CANCER CELL GROWTH INHIBITION AGENT, FEMALE CANCER TUMOR FORMATION INHIBITION AGENT, PHARMACEUTICAL, AND USE OF LONG-CHAIN NONCODING RNA UNIV SAITAMA MEDICAL [JP]
JP2022017865 (A) JP20200120675 20200714 CYTOTOXIC T CELL EPITOPE PEPTIDE OF SARS-COV-2 AND UTILIZATION THEREOF UNIV SAITAMA MEDICAL
US11447554 (B2); US2022041738 (A1) US202117511357 20211026 ANTI-ALK2 ANTIBODY UNIV SAITAMA MEDICAL [JP]; DAIICHI SANKYO CO LTD [JP]
WO2021260966 (A1) WO2020JP43886 20201125 COMPOSITION TARGETING ADENOSINE-PRODUCING ENZYME UNIV SAITAMA MEDICAL [JP]
JP2021188970 (A) JP20200092609 20200527 METHOD FOR EXAMINING LUNG CANCER BASED ON ANALYSIS OF PROTEIN COMPOSITE BODY IN EXTRACELLULAR VESICLE UNIV SAITAMA MEDICAL
JP2021181909 (A) JP20200086891 20200518 DIFFERENCE DETECTION CONJUGATE COMPENSATION CARS MEASUREMENT APPARATUS ATA CO LTD; UNIV SAITAMA MEDICAL
JP2021078705 (A) JP20190208388 20191119 MUSCLE RELAXATION MONITOR UNIV SAITAMA MEDICAL; ADTEX KK
WO2021084791 (A1) WO2020JP24876 20200624 COMPOSITION TARGETED TO ADENOSINE A2A RECEPTOR IMMNO INC [JP]; UNIV SAITAMA MEDICAL [JP]
JP2021048812 (A); JP7387357 (B2) JP20190175273 20190926 PRIMER SETS FOR DETECTING PRESENCE OR ABSENCE OF MUTATION IN BASE SEQUENCE ENCODING 83RD AMINO ACID OF GONOCOCCAL DNA GYRASE SUBUNIT A, PRIMER SETS FOR EVALUATING PRESENCE OR ABSENCE OF GONOCOCCAL SENSITIVITY TO FLUOROQUINOLONE AND USES THEREOF UNIV SAITAMA MEDICAL; NAT INSTITUTE OF INFECTIOUS DISEASES; UNIV NIHON
JP2021020862 (A); JP7422498 (B2) JP20190136589 20190725 PEPTIDE, CELL MIGRATION INHIBITOR, CELLULAR INFILTRATION INHIBITOR, CANCER CELL METASTASIS INHIBITOR, AND MEDICINE UNIV SAITAMA MEDICAL
JP2020198279 (A) JP20190105473 20190605 SECONDARY BATTERY REFRESH EFFECT PREDICTION SYSTEM, SECONDARY BATTERY REFRESH EFFECT PREDICTION DEVICE, SECONDARY BATTERY REFRESH EFFECT PREDICTION METHOD, AND PROGRAM UNIV SAITAMA MEDICAL; SHIN EI ELECTRONIC MEASURING CO LTD
JP2020187534 (A); JP7357266 (B2) JP20190091417 20190514 RADIO WAVE INTENSITY MONITORING SYSTEM TAISEI CORP; UNIV SAITAMA MEDICAL
BRPI1009855 (A2) BR2010PI09855 20100312 METHOD FOR DETERMINING SENSITIVITY TO IRINOTECAN AND USE THEREOF YAKULT HONSHA KK [JP]; UNIV SAITAMA MEDICAL [JP]
JP2020144012 (A) JP20190041046 20190306 STAINED IMAGE ESTIMATOR LEARNING DEVICE, IMAGE PROCESSING DEVICE, STAINED IMAGE ESTIMATOR LEARNING METHOD, IMAGE PROCESSING METHOD, STAINED IMAGE ESTIMATOR LEARNING PROGRAM, AND IMAGE PROCESSING PROGRAM UNIV SAITAMA MEDICAL; TOKYO INST TECH
WO2020137076 (A1) WO2019JP39415 20191004 METHOD FOR PREDICTING SUSCEPTIBILITY OF CANCER TO PARP INHIBITORS, AND METHOD FOR DETECTING CANCER HAVING HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY UNIV TOKYO [JP]; UNIV SAITAMA MEDICAL [JP]
JP2020093987 (A); JP7244821 (B2) JP20180231377 20181211 NEW COMPOUND WITH BONE METABOLISM INHIBITORY ACTIVITY AND MANUFACTURING METHOD THEREOF KITASATO INST; UNIV SAITAMA MEDICAL
JP2020081448 (A); JP7179288 (B2) JP20180221329 20181127 CATHETER OPERATION SUPPORT DEVICE AND METHOD, PROGRAM AND X-RAY MEDICAL SYSTEM R TECH KK; UNIV TOHOKU; UNIV SAITAMA MEDICAL; KOKURITSU IYAKUHIN SHOKUHIN EISEI KENKYUSHO; KOBE CITY HOSPITAL ORGANIZATION
US10835551 (B2); US2020121710 (A1) US202016732725 20200102 DOUBLE-STRANDED NUCLEIC ACID MOLECULE, DNA, VECTOR, CANCER CELL GROWTH INHIBITOR, CANCER CELL MIGRATION INHIBITOR, AND DRUG UNIV SAITAMA MEDICAL [JP]
JP2020048426 (A); JP7325075 (B2) JP20180177931 20180921 SCREENING AGENTS, SCREENING KITS, AND SCREENING METHODS FOR SCREENING AT LEAST ONE AGENT SELECTED FROM THE GROUP CONSISTING OF AGENTS FOR INCREASING OR REDUCING THE NUMBER OF CELLS OF FRIZZLED 3 EXPRESSING CELLS, DIABETES PREVENTION OR TREATMENT AGENTS, INSULINOMA PREVENTION OR TREATMENT AGENTS, AND INSULIN SECRETION PROMOTERS OR INHIBITORS UNIV SAITAMA MEDICAL
JP2020027052 (A); JP7191361 (B2) JP20180152478 20180813 METHOD FOR AIDING DETERMINATION OF AFFECTION POSSIBILITY OF GYNECOLOGY DISEASE, METHOD FOR COLLECTING DATA TO DIAGNOSE AFFECTION POSSIBILITY OF GYNECOLOGY DISEASE, AND DIAGNOSTIC KIT OF GYNECOLOGY DISEASE UNIV SAITAMA MEDICAL
JP2019198271 (A); JP7097606 (B2) JP20180094774 20180516 USE OF DOUBLE-STRANDED NUCLEIC ACID MOLECULES, DNA, VECTORS, CANCER CELL GROWTH INHIBITORS, MEDICINES, AND SPON1-TRIM29 FUSION GENES UNIV SAITAMA MEDICAL
JP2019190883 (A); JP7106810 (B2) JP20180080878 20180419 NEW LUNG CANCER MARKER UNIV SAITAMA MEDICAL
JP2019156807 (A); JP7064203 (B2) JP20180049308 20180316 ANTIHUMAN CD26 MONOCLONAL ANTIBODY JUNTENDO; UNIV SAITAMA MEDICAL
JP2019149987 (A) JP20180038978 20180305 METHOD FOR PREDICTING THE EFFECTIVENESS OF RADIOTHERAPY TO HEAD AND NECK SQUAMOUS CELL CARCINOMA UNIV SAITAMA MEDICAL
WO2019172213 (A1) WO2019JP08494 20190305 NANOPARTICLE, NANOPARTICLE PRODUCTION METHOD, AND ANTI-TUMOR AGENT NAT UNIV CORP YOKOHAMA NAT UNIV [JP]; UNIV SAITAMA MEDICAL [JP]; NAT INST INF & COMM TECH [JP]; UNIV OSAKA [JP]
JP2019131505 (A) JP20180014419 20180131 ANTI-CANCER AGENT UNIV KANAZAWA; UNIV SAITAMA MEDICAL
US2019189260 (A1) US201716324959 20170808 METHOD OF EVALUATING THERAPEUTIC EFFECT OF DRUG IN CANCER PATIENT, METHOD OF GENERATING EVALUATION DATA OF THERAPEUTIC EFFECT, THERAPEUTIC EFFECT EVALUATION DEVICE, AND THERAPEUTIC EFFECT EVALUATION PROGRAM UNIV SAITAMA MEDICAL [JP]; HAMAMATSU PHOTONICS KK [JP]
AR110928 (A1) AR2018P100290 20180207 BIOMARCADOR INMUNOLÓGICO PARA PREDECIR EL EFECTO CLÍNICO DE INMUNOTERAPIA DEL CÁNCER UNIV SAITAMA MEDICAL [JP]
US10809200 (B2); US2019137402 (A1) US201716309732 20170616 TEST OBJECT VISUALIZING DEVICE UNIV SAITAMA MEDICAL [JP]
JP2019045540 (A); JP6901072 (B2) JP20170165001 20170830 IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND IMAGE PROCESSING PROGRAM UNIV SAITAMA MEDICAL
JP2019174432 (A); JP6454950 (B1) JP20180077994 20180329 SIMPLE MEASURING METHOD AND MEASURING DEVICE FOR OXIDIZABLE VLDL (VLDL SUSCEPTIBILITY TO OXIDATION) AND OXIDIZABLE LDL (LDL SUSCEPTIBILITY TO OXIDATION) THAT ARE JUDGED TO HAVE HIGH RISK OF MYOCARDIAL INFARCTION AND CEREBRAL INFARCTION DUE TO ATHEROSCLEROSIS ASKA SPECIAL LABORATORY CO LTD; UNIV SAITAMA MEDICAL; NAT CEREBRAL & CARDIOVASCULAR CT
CN109182376 (A); CN109182376 (B) CN201811123541 20131029 Method of manufacturing differentiated pluripotent stem cell UNIV SAITAMA MEDICAL
WO2018221562 (A1) WO2018JP20696 20180530 COMPOSITION FOR INHIBITING PRODUCTION OF IL-8 FROM ACTIVATED T CELL IMMNO INC [JP]; UNIV SAITAMA MEDICAL [JP]
JP2018175579 (A); JP6497531 (B2) JP20170082048 20170418 ANKLE HEMODYNAMICS INDEX CALCULATION DEVICE, ANKLE HEMODYNAMICS INDEX CALCULATION METHOD, ANKLE HEMODYNAMICS INDEX CALCULATION PROGRAM, AND BLOOD PRESSURE MEASURING DEVICE UNIV SAITAMA MEDICAL
US11499140 (B2); US2018312812 (A1) US201615770910 20161028 Method for Producing Pancreatic Endocrine Cells, and Transdifferentiation Agent UNIV SAITAMA MEDICAL [JP]
JP2018124913 (A); JP6879752 (B2) JP20170018649 20170203 MEDICAL DEVICE MONITORING SYSTEM HITACHI SYSTEMS LTD; UNIV SAITAMA MEDICAL
US10370730 (B2); US2018163278 (A1) US201415103184 20141211 DETECTION METHOD FOR MUTATION IN 93RD AMINO ACID OF HEPATITIS C VIRUS NS5A PROTEIN, AND DETECTION KIT FOR MUTATION IN 93RD AMINO ACID OF HEPATITIS C VIRUS NS5A PROTEIN UNIV SAITAMA MEDICAL
JP2018067203 (A) JP20160206293 20161020 DANGER NOTIFICATION DEVICE, DANGER NOTIFICATION METHOD, AND CALIBRATION METHOD FOR DANGER NOTIFICATION DEVICE UNIV SAITAMA MEDICAL
JP2018008915 (A); JP6727051 (B2) JP20160140818 20160715 THICKENING AGENT, COMPOSITION KIT, AND METHOD FOR THICKENING COMPOSITION UNIV SAITAMA MEDICAL; KURINIKO KK; MORINAGA MILK INDUSTRY CO LTD
JP2017217037 (A) JP20160111350 20160602 APPLICATOR FOR UTERINE CANCER INTRACAVITARY IRRADIATION, RADIATION TREATMENT PLANNING METHOD OF UTERINE CANCER AND RADIATION TREATMENT PLANNING DEVICE OF UTERINE CANCER UNIV SAITAMA MEDICAL; UNIV GUNMA
JP2017203816 (A); JP6714258 (B2) JP20160094053 20160509 OPTICAL PARAMETRIC OSCILLATOR ATA CO LTD; UNIV SAITAMA MEDICAL
JP2017203646 (A); JP6606803 (B2) JP20160094042 20160509 FREQUENCY MODULATION CARS MEASUREMENT DEVICE ATA CO LTD; UNIV SAITAMA MEDICAL
US10669613 (B2); US2017327928 (A1) US201715668107 20170803 TITANIUM ALLOY NIPPON PISTON RING CO LTD [JP]; NATIONAL UNIV CORPORATION SAITAMA UNIV [JP]
CN106983859 (A) CN20161141668 20161122 A preparing method of an immunity inducer SYSMEX CORP; HIROSHI HANDA; UNIV SAITAMA MEDICAL
US10214728 (B2); US2017211046 (A1) US201515323576 20150703 PANCREATIC ENDOCRINE CELLS, METHOD FOR PRODUCING SAME, AND TRANSDIFFERENTIATION AGENT UNIV SAITAMA MEDICAL [JP]
JP2017119691 (A); JP6927483 (B2) JP20160250667 20161226 NOVEL COMPOUND HAVING BONE METABOLISM INHIBITORY ACTIVITY AND METHOD FOR PRODUCING THE SAME KITASATO INST; UNIV SAITAMA MEDICAL
JP2017114835 (A); JP6715004 (B2) JP20150255012 20151225 IMMUNOSTIMULANT AND PRODUCTION METHOD THEREFOR HANDA HIROSHI; UNIV SAITAMA MEDICAL; SYSMEX CORP
JP2017109965 (A); JP6778365 (B2) JP20150246912 20151218 ANTI-PANCREATIC POLYPEPTIDE MONOCLONAL ANTIBODY JUNTENDO; UNIV SAITAMA MEDICAL
JP2017079730 (A); JP6985691 (B2) JP20160207898 20161024 METHODS FOR PREDICTING THERAPEUTIC EFFECTS OF BIOLOGICAL PREPARATION FOR RHEUMATOID ARTHRITIS, AND METHODS FOR SELECTING OPTIMAL DRUG USING THE SAME DNA CHIP RESEARCH INC; KEIO GIJUKU; UNIV SAITAMA MEDICAL
JP2016198203 (A); JP6484091 (B2) JP20150079160 20150408 EXAMINATION METHOD OF STOP POSITION IN APPLICATOR OF GUIDE WIRE TIP SMALL LINE SOURCE AND EXAMINATION TOOL UNIV SAITAMA MEDICAL; AARUTEKKU KK
US2016311875 (A1); US9856304 (B2) US201414893730 20140523 NEW PEPTIDE AND APPLICATION THEREOF UNIV SAITAMA MEDICAL [JP]
JP2016134437 (A); JP6742690 (B2) JP20150006924 20150116 FIBER RING LASER, OPTICAL PULSE AND OPTICAL TOMOGRAPHIC IMAGING DEVICE UNIV SAITAMA MEDICAL
JP2016131705 (A); JP5946927 (B1) JP20150007759 20150119 SURGICAL SPECIMEN RECOVERY FORCEPS AND SURGICAL SPECIMEN RECOVERY BAG UNIV SAITAMA MEDICAL
JP2016121097 (A); JP6432114 (B2) JP20140261988 20141225 DRUGS FOR INDUCING IMMUNE RESPONSE IMUNO:KK; UNIV SAITAMA MEDICAL
WO2016098873 (A1) WO2015JP85435 20151218 METHOD FOR DETERMINING RISK OF DEVELOPING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, AND COMPOSITION FOR TREATING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA UNIV TOKYO [JP]; UNIV SAITAMA MEDICAL [JP]; KYORIN UNIVERSITY [JP]
JP2016077574 (A) JP20140212372 20141017 IDENTIFICATION MARKER AND MEDICAL SUPPORT SYSTEM BY AUGMENTED REALITY TECHNOLOGY USING THE SAME UNIV SAITAMA MEDICAL
JP2016070798 (A) JP20140200824 20140930 METHOD FOR ASSISTING DETERMINATION OF BEHCET'S DISEASE AND METHOD FOR ASSISTING EVALUATION OF ACTIVITY OF BEHCET'S DISEASE UNIV SAITAMA MEDICAL
JP2016045996 (A); JP6353739 (B2) JP20140167252 20140820 ELECTRIC CONDUCTION UNIT, SLOPE STATE DETECTION DEVICE AND SLOPE STATE DETECTION METHOD UNIV SAITAMA MEDICAL; YAMAKEI:KK
WO2016047509 (A1) WO2015JP76214 20150916 PEPTIDE-BOUND LIPOSOME, CYTOTOXIC T LYMPHOCYTE ACTIVATOR, AND ANTITUMOR VACCINE UNIV SAITAMA MEDICAL [JP]
JP2016037473 (A); JP6370634 (B2) JP20140162011 20140808 MALE STERILITY PREVENTIVE/THERAPEUTIC AGENT, AND FOOD/FEED UNIV SAITAMA MEDICAL
US2016002734 (A1); US9873920 (B2) US201414771465 20140227 METHOD FOR EVALUATING SIDE-EFFECT ONSET RISK IN ANTICANCER DRUG TREATMENT, INCLUDING DETECTING MUC4 GENE POLYMORPHISM UNIV SAITAMA MEDICAL [JP]
JP2015154718 (A) JP20140030106 20140219 COLONY-COUNTING APPARATUS, COLONY-COUNTING METHOD, AND COLONY-COUNTING PROGRAM UNIV SAITAMA MEDICAL
US10413559 (B2); US2015352132 (A1) US201414763618 20140128 THERAPEUTIC AGENT FOR DEMYELINATING DISEASE OCHANOMIZU UNIVERSITY [JP]; UNIV SAITAMA MEDICAL [JP]
US2015343089 (A1); US9814785 (B2) US201514831539 20150820 HEPATITIS C VIRUS LIPOSOME VACCINE UNIV SAITAMA MEDICAL [JP]; JAPAN AS REPRESENTED BY THE DIRECTOR GENERAL OF NAT INST OF INFECTIOUS DISEASES [JP]; NOF CORP [JP]
JP2015141282 (A); JP6255257 (B2) JP20140013438 20140128 MEASURING DEVICE AND MEASURING METHOD UNIV SAITAMA MEDICAL
JP2015139398 (A) JP20140013666 20140128 APPARATUS AND METHOD FOR NUCLEIC ACID EXTRACTION LIFETECH CO LTD; UNIV SAITAMA MEDICAL
WO2015115221 (A1) WO2015JP51194 20150119 MEASURING DEVICE AND MEASURING METHOD UNIV SAITAMA MEDICAL [JP]
US10213319 (B2); US2015157468 (A1) US201314410437 20130810 NAVIGATION DEVICE FOR JOINT REPLACEMENT AND SURGICAL SUPPORT DEVICE ARTHRODESIGN LTD [JP]; LEXI CO LTD [JP]; UNIV SAITAMA MEDICAL [JP]
US2015140661 (A1) US201314403026 20130524 METHOD FOR PRODUCING PANCREATIC HORMONE-PRODUCING CELL, PANCREATIC HORMONE-PRODUCING CELL, AND DIFFERENTIATION/INDUCTION PROMOTER UNIV SAITAMA MEDICAL [JP]
JP2015084939 (A); JP5969447 (B2) JP20130225850 20131030 ANALYZER OF ERROR BETWEEN RADIATION IRRADIATION FIELD AND LIGHT IRRADIATION FIELD IN RADIOTHERAPY APPARATUS UNIV SAITAMA MEDICAL; AARUTEKKU KK
US2015045244 (A1) US201114358517 20111117 METHOD FOR DETERMINING RHEUMATOID ARTHRITIS ACTIVITY INDICATOR, AND BIOMARKER USED THEREIN TAKEUCHI TSUTOMU [JP]; AMANO KOICHI [JP]; ISHIZAWA YOHEI [JP]; NAKAMURA SEIJI [JP]; TANINO MOTOHIKO [JP]; HATA YUKO [JP]; DNA CHIP RESEARCH INC [JP]; UNIV SAITAMA MEDICAL [JP]; UNIV KEIO [JP]
JP2015002713 (A); JP6210752 (B2) JP20130130358 20130621 PRODUCTION METHOD OF NON-HUMAN MODEL ANIMAL WITH ENHANCED PHOSPHORYLATION OF TAU PROTEIN UNIV SAITAMA MEDICAL
US2015005641 (A1); US9521953 (B2) US201314381021 20130226 MEASUREMENT DEVICE AND MEASUREMENT METHOD UNIV SAITAMA MEDICAL [JP]
US2015002934 (A1); US9612449 (B2) US201314377288 20130207 AXIALLY SYMMETRIC POLARIZATION CONVERSION ELEMENT UNIV SAITAMA MEDICAL [JP]; UNIV UTSUNOMIYA [JP]
WO2014192927 (A1) WO2014JP64452 20140530 COMPUTER SIMULATION SYSTEM UNIV KYOTO [JP]; UNIV SAITAMA MEDICAL [JP]
JP2014217345 (A) JP20130100312 20130510 COMPOSITION FOR PRODUCING INDUCED PLURIPOTENT STEM CELL, AND METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELL UNIV SAITAMA MEDICAL
JP2014217344 (A) JP20130100311 20130510 COMPOSITION FOR PRODUCING INDUCED PLURIPOTENT STEM CELL, AND METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELL UNIV SAITAMA MEDICAL
JP2014217339 (A); JP6321921 (B2) JP20130099962 20130510 ANTI-TLS MONOCLONAL ANTIBODY AND METHOD FOR PRODUCING THE SAME, HYBRIDOMA AND METHOD FOR PRODUCING THE SAME, AND ANTI-TLS MONOCLONAL ANTIBODY-CONTAINING COMPOSITION UNIV SAITAMA MEDICAL
US2014350073 (A1); US9284557 (B2) US201414324803 20140707 DOUBLE-STRANDED NUCLEIC ACID MOLECULE, CANCER CELL PROLIFERATION INHIBITOR AND PHARMACEUTICAL AGENT SUITABLE FOR PREVENTION OR TREATMENT OF CANCER UNIV SAITAMA MEDICAL [JP]; RNAI CO LTD [JP]
WO2014181682 (A1) WO2014JP61378 20140423 COMPOSITION FOR MANUFACTURING INDUCED PLURIPOTENT STEM CELL AND METHOD FOR MANUFACTURING INDUCED PLURIPOTENT STEM CELL UNIV SAITAMA MEDICAL [JP]
WO2014148529 (A1) WO2014JP57471 20140319 DOUBLE-STRANDED NUCLEIC ACID MOLECULE, DNA, VECTOR, CANCER CELL PROLIFERATION INHIBITOR, AND PHARMACEUTICAL PRODUCT UNIV SAITAMA MEDICAL [JP]
JP2014153343 (A); JP5930984 (B2) JP20130026271 20130214 SHAPE MEASUREMENT DEVICE UNIV SAITAMA MEDICAL
US2014286978 (A1) US201214117575 20120424 CYTOTOXIC T LYMPHOCYTE INDUCER TOKYO INST TECH [JP]; LSIP LLC [JP]; UNIV SAITAMA MEDICAL [JP]; LSIP LLC [JP]
WO2014042167 (A1) WO2013JP74452 20130911 MONOCLONAL ANTIBODY AGAINST EBAG9, HYBRIDOMA, AND APPLICATION FOR MONOCLONAL ANTIBODY AGAINST EBAG9 UNIV SAITAMA MEDICAL [JP]
JP2014212374 (A); JP5396559 (B1) JP20130086355 20130417 IMAGE ENCODING DEVICE, IMAGE ENCODING METHOD, IMAGE ENCODING PROGRAM, AND RECORDING MEDIUM UNIV SAITAMA MEDICAL
JP2014005205 (A) JP20100231918 20101014 EBOLA VIRUS LIPOSOME VACCINE UNIV SAITAMA MEDICAL; NAT INST INFECTIOUS DISEASES; NOF CORP
US2014030742 (A1); US9458210 (B2) US201214008677 20120402 ANTIBODY REACTING WITH NATIVE COCHLIN-TOMOPROTEIN (CTP) AND METHOD FOR MEASURING CTP USING SAME IKEZONO TETSUO [JP]; SHIKAZE SATOMI [JP]; UNIV SAITAMA MEDICAL [JP]
JP2013255488 (A) JP20130102114 20130514 NON-HUMAN ANIMAL MODEL OF DIASTOLIC HEART FAILURE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR SCREENING SUBSTANCE HAVING DIASTOLIC HEART FAILURE PREVENTING OR SYMPTOM IMPROVING ACTIVITY UNIV SAITAMA MEDICAL
JP2013234981 (A); JP6019288 (B2) JP20120116943 20120507 METHOD OF SIMPLY CLASSIFYING OR DETERMINING PHENOTYPE OF DYSLIPIDEMIA OR HYPERLIPEMIA ASKA SPECIAL LAB CO LTD; UNIV SAITAMA MEDICAL
WO2013183702 (A1) WO2013JP65679 20130606 HELPER-DEPENDENT ADENOVIRUS VECTOR, METHOD FOR VISUALIZING MATURE OSTEOBLASTS, AND METHOD FOR PRODUCING MATURE OSTEOBLASTS UNIV SAITAMA MEDICAL [JP]
JP2013225257 (A) JP20120098038 20120423 UNSAFE ACTION DETECTION SYSTEM AND UNSAFE ACTION DETECTION METHOD SEIKO EPSON CORP; UNIV SAITAMA MEDICAL
JP2013220148 (A) JP20120092373 20120413 UNSAFE BEHAVIOR DETECTION DEVICE AND UNSAFE BEHAVIOR DETECTION METHOD SEIKO EPSON CORP; UNIV SAITAMA MEDICAL
JP2013205411 (A); JP5953897 (B2) JP20120091395 20120328 METHOD FOR DETERMINING PARTICLE DIAMETER OF LIPOPROTEIN AND PARTICLE MARKER OF LIPOPROTEIN ASKA SPECIAL LAB CO LTD; UNIV SAITAMA MEDICAL
US2013252241 (A1) US201313872631 20130429 METHOD OF DISTINGUISHING INFLAMMATORY PATHOGEN CAUSING ACUTE RESPIRATORY INFECTION UNIV SAITAMA MEDICAL [JP]
JP2013126422 (A); JP5721150 (B2) JP20130052314 20130314 METHOD FOR PREDICTING ONSET RISK OF AGE-RELATED MACULAR DEGENERATION UNIV SAITAMA MEDICAL
DK2168589 (T3) DK20070791094T 20070720 INSULIN SECRETION INDUCER, AND ACCELERATOR FOR INCREASING THE NUMBER OF PANCREATIC ß-CELLS UNIV SAITAMA MEDICAL [JP]
JP2013081430 (A); JP6024939 (B2) JP20110224666 20111012 METHOD OF MEASURING DRUG-METABOLIZING FUNCTION UNIV KANAZAWA; UNIV SAITAMA MEDICAL
JP2013053850 (A) JP20100002301 20100107 CIRCULARLY POLARIZED LIGHT CONVERSION DEVICE UNIV SAITAMA MEDICAL
US2013011921 (A1) US201113578777 20110215 METHOD FOR PRODUCTION OF ARTIFICIAL PLURIPOTENT STEM CELL UNIV SAITAMA MEDICAL [JP]; HISHIDA TOMOAKI [JP]; OKUDA AKIHIKO [JP]; KATO HIDEMASA [JP]
WO2012147757 (A1) WO2012JP61016 20120425 METHOD AND KIT FOR DETERMINING AGE-RELATED MACULAR DEGENERATION VULNERABILITY UNIV SAITAMA MEDICAL [JP]; SANTEN PHARMACEUTICAL CO LTD [JP]; INOUE SATOSHI [JP]; INOUE KUNIKO [JP]; MORI KEISUKE [JP]; YONEYA SHIN [JP]; KOHDA MASAKAZU [JP]; OKAZAKI YASUSHI [JP]
US2012214183 (A1); US8993254 (B2) US201013504413 20101026 METHODS FOR EVALUATING RISK OF MOTHER'S MILK OR FOOD INDUCING AN ONSET OF ATOPIC DERMATITIS, AND MOTHER'S MILK OR FOOD WITH REDUCED RISK OF INDUCING AN ONSET OF ATOPIC DERMATITIS MATSUSHITA SHO [JP]; HIGASHI TAKEHIRO [JP]; UNIV SAITAMA MEDICAL [JP]; IMMNO INC [JP]
JP2012105555 (A); JP5725469 (B2) JP20100255134 20101115 BONE DIFFERENTIATION INHIBITOR AND METHOD FOR PRODUCING THE SAME KITASATO INST; UNIV SAITAMA MEDICAL
WO2012074085 (A1) WO2011JP77890 20111202 MARKER FOR DETERMINATION OF SENSITIVITY TO TRIPLET COMBINATION ANTI-CANCER AGENT UNIV SAITAMA MEDICAL [JP]; YAKULT HONSHA KK [JP]; NISHIYAMA MASAHIKO [JP]; EGUCHI HIDETAKA [JP]; WADA SATORU [JP]
JP2012021951 (A) JP20100162031 20100716 SOFT X-RAY MICROSCOPE UNIV SAITAMA MEDICAL
CN102232083 (A); CN102232083 (B) CN200980147542 20091127 Avian influenza vaccine JAPAN AS REPRESENTED BY THE DI; UNIV HOKKAIDO NAT UNIV CORP; UNIV SAITAMA MEDICAL; NOF CORP
US2011262529 (A1); US8828929 (B2) US200913131560 20091127 CYTOTOXIC T CELL EPITOPE PEPTIDE FOR SARS CORONAVIRUS, AND USE THEREOF NOF CORP [JP]; JP NAT INST OF INFECTIOUS DISEASES [JP]; UNIV SAITAMA MEDICAL [JP]
WO2011126050 (A1) WO2011JP58724 20110406 POLYMER MOLDED BODY FOR PULLING BIOLOGICAL TISSUE, MEDICAL PULLING MEMBER USING SAME, AND MEDICAL PULLING TOOL HITACHI CHEMICAL CO LTD [JP]; UNIV SAITAMA MEDICAL [JP]; KOBAYASHI KAZUTOSHI [JP]; SUTO KUNIHIRO [JP]; NISHIMURA MAKOTO [JP]; KITA HIROTO [JP]
JP2011135838 (A); JP5706612 (B2) JP20090298772 20091228 MARKER, METHOD AND KIT FOR JUDGING LIABILITY TO AGE-RELATED MACULAR DEGENERATION UNIV SAITAMA MEDICAL; SANTEN PHARMACEUTICAL CO LTD
WO2011087009 (A1) WO2011JP50331 20110112 REGULATORY GENE CONTROLLING SACCHAROMETABOLISM, LIPID METABOLISM, OBESITY AND LIFE, PROTEIN, AND SCREENING METHOD UNIV SAITAMA MEDICAL [JP]; INOUE SATOSHI [JP]; IKEDA KAZUHIRO [JP]
JP2011126853 (A) JP20090289848 20091221 AVIAN INFLUENZA VACCINE NAT INST OF INFECTIOUS DISEASES; UNIV HOKKAIDO; UNIV SAITAMA MEDICAL; NOF CORP
JP2010263818 (A) JP20090116845 20090513 NEW PPARgamma PROMOTER SEQUENCE AND APPLICATION THEREOF UNIV SAITAMA MEDICAL; NAT INST OF ADVANCED IND SCIEN
JP2010233498 (A) JP20090085128 20090331 Th21 CELL CLONE AND PRODUCTION AND USE OF THE SAME IMUNO KK; UNIV SAITAMA MEDICAL
JP2010230565 (A); JP5308208 (B2) JP20090079895 20090327 APPARATUS AND METHOD FOR MEASUREMENT OF POLARIZATION CHARACTERISTICS UNIV SAITAMA MEDICAL; UNIV TOKYO AGRICULTURE
JP2010213585 (A) JP20090061208 20090313 OSTEOBLAST DIFFERENTIATION MARKER, OSTEOGENESIS PROMOTER, AND OSTEOGENESIS INHIBITOR UNIV SAITAMA MEDICAL
JP2010210410 (A) JP20090056756 20090310 THREE-DIMENSIONAL SHAPE MEASURING DEVICE UNIV SAITAMA MEDICAL
JP2010172307 (A) JP20090020915 20090130 METHOD AND APPARATUS FOR PREDICTING PHARMACOLOGICAL EFFICACY OF SOLUBLE TNFalpha/LTalpha RECEPTOR PREPARATION ON RHEUMATOID ARTHRITIS UNIV SAITAMA MEDICAL
US2010173405 (A1); US8124754 (B2) US20090642979 20091221 Double-Stranded Nucleic Acid Molecule Cancer Cell Proliferation Inhibitor and Pharmaceutical Agent Suitable for Prevention or Treatment of Uterine Cancer, Breast Cancer, and Bladder Cancer UNIV SAITAMA MEDICAL [JP]; RNAI CO LTD [JP]
JP2010111581 (A) JP20070014786 20070125 MEDICINE CONTAINING DOPAMINE D2-LIKE RECEPTOR AGONIST AS ACTIVE INGREDIENT AND SCREENING METHOD IMUNO KK; UNIV SAITAMA MEDICAL
JP2010094062 (A) JP20080266721 20081015 MEDIUM, CULTURE METHOD AND DIFFERENTIATION METHOD FOR MAINTAINING PLURIPOTENCY OF MESENCHYMAL STEM CELL UNIV SAITAMA MEDICAL
JP2010064957 (A) JP20080229880 20080908 AGENT FOR PREVENTING OR TREATING DISEASE RELATED TO KLOTHO AND FGF23, CONTAINING CALCIMIMETIC AS ACTIVE INGREDIENT UNIV SAITAMA MEDICAL; KYOWA HAKKO KIRIN CO LTD
JP2010030956 (A) JP20080195099 20080729 PROMOTER AND INHIBITOR OF OSTEOBLAST CELL DIFFERENTIATION, OSTEOGENESIS PROMOTER, OSTEOPOROSIS DRUG, ANTI-OBESITY AGENT, AND SCREENING METHOD UNIV SAITAMA MEDICAL
JP2010024198 (A) JP20080189427 20080723 PHARMACEUTICAL FOR TREATING AND PREVENTING TYPE 1 DIABETES COMPRISING DOPAMINE D2-LIKE RECEPTOR AGONIST AS EFFECTIVE COMPONENT, AND SCREENING METHOD IMUNO KK; UNIV SAITAMA MEDICAL
JP2010004794 (A) JP20080167267 20080626 EVALUATION METHOD OF TH17 ADJUVANT ACTIVITY AND INHIBITION OF ACTIVITY BY USING EXPRESSION OF HUMAN JAGGED1 GENE AS INDEX, AND SCREENING METHOD OF SUBSTANCE HAVING TH17 ADJUVANT ACTIVITY AND SUBSTANCE INHIBITING ACTIVITY IMUNO KK; UNIV SAITAMA MEDICAL
US2009155782 (A1) US20060988812 20060707 Homoeologous Region Determining Method by Homo Junction Fingerprint Method, Homoeologous Region Determining Device, and Gene Screening Method TOMY DIGITAL BIOLOGY CO LTD [JP]; UNIV SAITAMA MEDICAL [JP]
JP2009073745 (A) JP20070242895 20070919 PROPHYLACTIC/THERAPEUTIC AGENT FOR MENSTRUATION-RELATED MIGRAINE, MENSTRUAL PAIN AND MENOPAUSAL DISORDER UNIV SAITAMA MEDICAL
.